Price T Rowe Associates Inc Vbi Vaccines Inc Transaction History

Price T Rowe Associates Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.38 - $22.5 $19,532 - $1.16 Million	-51,400 Reduced 22.22%	179,906 $70,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $23.4 $32,099 - $1.03 Million	43,972 Added 23.47%	231,306 $165,000
Q2 2022 Aug 15, 2022	BUY	$0.66 - $1.81 $34,137 - $93,620	51,724 Added 38.14%	187,334 $151,000
Q1 2022 May 16, 2022	BUY	$1.27 - $2.47 $21,550 - $41,913	16,969 Added 14.3%	135,610 $225,000
Q4 2021 Feb 14, 2022	BUY	$2.21 - $3.22 $16,738 - $24,388	7,574 Added 6.82%	118,641 $278,000
Q3 2021 Nov 15, 2021	BUY	$2.8 - $3.72 $1,680 - $2,232	600 Added 0.54%	111,067 $345,000
Q2 2021 Aug 16, 2021	BUY	$2.61 - $4.17 $6,240 - $9,970	2,391 Added 2.21%	110,467 $370,000
Q1 2021 May 17, 2021	BUY	$2.91 - $4.32 $2,060 - $3,058	708 Added 0.66%	108,076 $336,000
Q4 2020 Feb 16, 2021	BUY	$2.15 - $3.5 $230,841 - $375,788	107,368 New	107,368 $295,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.